Total Payments
$48,036
2024 Payments
$1,854
Companies
1
Transactions
65
Medicare Patients
119,847
Medicare Billing
$4.7M
Payment Breakdown by Category
Consulting$48,036 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $48,036 | 65 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $48,036 | 65 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,854 | 4 | Merck Sharp & Dohme LLC ($1,854) |
| 2023 | $3,186 | 6 | Merck Sharp & Dohme LLC ($3,186) |
| 2022 | $461.50 | 1 | Merck Sharp & Dohme LLC ($461.50) |
| 2021 | $3,672 | 5 | Merck Sharp & Dohme LLC ($3,672) |
| 2020 | $7,488 | 11 | Merck Sharp & Dohme Corporation ($7,488) |
| 2019 | $10,288 | 13 | Merck Sharp & Dohme Corporation ($10,288) |
| 2018 | $8,575 | 10 | Merck Sharp & Dohme Corporation ($8,575) |
| 2017 | $12,513 | 15 | Merck Sharp & Dohme Corporation ($12,513) |
All Payment Transactions
65 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/02/2024 | Merck Sharp & Dohme LLC | — | Consulting Fee | Cash or cash equivalent | $520.00 | General |
| Category: VACCINE | ||||||
| 12/02/2024 | Merck Sharp & Dohme LLC | — | Consulting Fee | Cash or cash equivalent | $97.50 | General |
| Category: VACCINE | ||||||
| 06/26/2024 | Merck Sharp & Dohme LLC | — | Consulting Fee | Cash or cash equivalent | $780.00 | General |
| Category: VACCINE | ||||||
| 06/24/2024 | Merck Sharp & Dohme LLC | — | Consulting Fee | Cash or cash equivalent | $456.30 | General |
| Category: VACCINE | ||||||
| 10/11/2023 | Merck Sharp & Dohme LLC | — | Consulting Fee | Cash or cash equivalent | $456.30 | General |
| Category: VACCINE | ||||||
| 07/26/2023 | Merck Sharp & Dohme LLC | — | Consulting Fee | Cash or cash equivalent | $292.50 | General |
| Category: VACCINE | ||||||
| 07/17/2023 | Merck Sharp & Dohme LLC | — | Consulting Fee | Cash or cash equivalent | $975.00 | General |
| Category: VACCINE | ||||||
| 06/14/2023 | Merck Sharp & Dohme LLC | — | Consulting Fee | Cash or cash equivalent | $650.00 | General |
| Category: VACCINE | ||||||
| 01/11/2023 | Merck Sharp & Dohme LLC | — | Consulting Fee | Cash or cash equivalent | $487.50 | General |
| Category: VACCINE | ||||||
| 01/11/2023 | Merck Sharp & Dohme LLC | — | Consulting Fee | Cash or cash equivalent | $325.00 | General |
| Category: VACCINE | ||||||
| 06/22/2022 | Merck Sharp & Dohme LLC | — | Consulting Fee | Cash or cash equivalent | $461.50 | General |
| Category: VACCINE | ||||||
| 12/08/2021 | Merck Sharp & Dohme LLC | — | Consulting Fee | Cash or cash equivalent | $812.50 | General |
| Category: VACCINE | ||||||
| 07/01/2021 | Merck Sharp & Dohme LLC | — | Consulting Fee | Cash or cash equivalent | $1,137.50 | General |
| Category: VACCINE | ||||||
| 02/03/2021 | Merck Sharp & Dohme LLC | — | Consulting Fee | Cash or cash equivalent | $350.00 | General |
| Category: VACCINE | ||||||
| 01/20/2021 | Merck Sharp & Dohme LLC | — | Consulting Fee | Cash or cash equivalent | $759.50 | General |
| Category: VACCINE | ||||||
| 01/20/2021 | Merck Sharp & Dohme LLC | — | Consulting Fee | Cash or cash equivalent | $612.50 | General |
| Category: VACCINE | ||||||
| 11/25/2020 | Merck Sharp & Dohme Corporation | V114 (Biological) | Consulting Fee | Cash or cash equivalent | $350.00 | General |
| Category: VACCINE | ||||||
| 11/16/2020 | Merck Sharp & Dohme Corporation | V114 (Biological) | Consulting Fee | Cash or cash equivalent | $350.00 | General |
| Category: VACCINE | ||||||
| 06/24/2020 | Merck Sharp & Dohme Corporation | GARDASIL (Biological) | Consulting Fee | Cash or cash equivalent | $350.00 | General |
| Category: VACCINE | ||||||
| 06/10/2020 | Merck Sharp & Dohme Corporation | V114 (Biological) | Consulting Fee | Cash or cash equivalent | $787.50 | General |
| Category: VACCINE | ||||||
| 06/10/2020 | Merck Sharp & Dohme Corporation | V114 (Biological) | Consulting Fee | Cash or cash equivalent | $700.00 | General |
| Category: VACCINE | ||||||
| 04/06/2020 | Merck Sharp & Dohme Corporation | GARDASIL (Biological) | Consulting Fee | Cash or cash equivalent | $350.00 | General |
| Category: VACCINE | ||||||
| 03/06/2020 | Merck Sharp & Dohme Corporation | V114 (Biological) | Consulting Fee | Cash or cash equivalent | $1,050.00 | General |
| Category: VACCINE | ||||||
| 02/19/2020 | Merck Sharp & Dohme Corporation | GARDASIL (Biological) | Consulting Fee | Cash or cash equivalent | $1,050.00 | General |
| Category: VACCINE | ||||||
| 01/15/2020 | Merck Sharp & Dohme Corporation | V114 (Biological) | Consulting Fee | Cash or cash equivalent | $700.00 | General |
| Category: VACCINE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 13,881 | 13,907 | $1.3M | $975,589 |
| 2022 | 15 | 18,044 | 18,150 | $962,268 | $765,098 |
| 2021 | 14 | 79,877 | 79,957 | $2.9M | $2.6M |
| 2020 | 4 | 8,045 | 8,045 | $425,297 | $286,784 |
Total Patients
119,847
Total Services
120,059
Medicare Billing
$4.7M
Procedure Codes
40
All Medicare Procedures & Services
40 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 91322 | Sarscov2 vac 50 mcg/0.5ml im | Office | 2023 | 3,424 | 3,425 | $595,950 | $489,632 | 82.2% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 3,269 | 3,279 | $301,590 | $235,721 | 78.2% |
| 90480 | Admn sarscov2 vacc 1 dose | Office | 2023 | 3,424 | 3,425 | $188,375 | $136,549 | 72.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 3,411 | 3,423 | $188,007 | $102,273 | 54.4% |
| 0124A | Adm sarscv2 bvl 30mcg/.3ml a | Office | 2023 | 121 | 121 | $4,840 | $4,743 | 98.0% |
| 0134A | Adm sarscv2 bvl 50mcg/.5ml a | Office | 2023 | 90 | 90 | $3,600 | $3,528 | 98.0% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2023 | 142 | 144 | $4,887 | $3,142 | 64.3% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 3,541 | 3,547 | $339,701 | $241,587 | 71.1% |
| 0124A | Fee covid-19 vac 13 res | Office | 2022 | 3,370 | 3,371 | $134,840 | $131,098 | 97.2% |
| 0054A | Adm sarscv2 30mcg trs-sucr b | Office | 2022 | 2,987 | 3,009 | $120,360 | $118,092 | 98.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 3,751 | 3,761 | $190,886 | $103,561 | 54.3% |
| 0064A | Adm sarscov2 50mcg/0.25mlbst | Office | 2022 | 1,798 | 1,861 | $74,440 | $73,157 | 98.3% |
| 0134A | Fee covid-19 vac 14 res | Office | 2022 | 1,820 | 1,820 | $72,800 | $70,780 | 97.2% |
| 0004A | Adm sarscov2 30mcg/0.3ml bst | Office | 2022 | 460 | 460 | $18,400 | $18,253 | 99.2% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2022 | 207 | 211 | $6,357 | $4,444 | 69.9% |
| 0053A | Adm sarscv2 30mcg trs-sucr 3 | Office | 2022 | 29 | 29 | $1,160 | $1,146 | 98.8% |
| 0002A | Intramuscular administration of single severe acute respiratory syndrome coronavirus 2 (covid-19) vaccine, mrna-lnp, spike protein, preservative free, 30 mcg/0.3ml dosage, diluent reconstituted; second dose | Office | 2022 | 17 | 17 | $680.00 | $674.56 | 99.2% |
| 0013A | Adm sarscov2 100mcg/0.5ml3rd | Office | 2022 | 16 | 16 | $640.00 | $634.09 | 99.1% |
| 0012A | Intramuscular administration of single severe acute respiratory syndrome coronavirus 2 (covid-19) vaccine, mrna-lnp, spike protein, preservative free, 100 mcg/0.5ml dosage; second dose | Office | 2022 | 12 | 12 | $480.00 | $474.16 | 98.8% |
| 0051A | Adm sarscv2 30mcg trs-sucr 1 | Office | 2022 | 11 | 11 | $440.00 | $431.33 | 98.0% |
| 0052A | Adm sarscv2 30mcg trs-sucr 2 | Office | 2022 | 11 | 11 | $440.00 | $430.94 | 97.9% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2022 | 14 | 14 | $644.00 | $335.16 | 52.0% |
| 0002A | Adm sarscov2 30mcg/0.3ml 2nd | Office | 2021 | 18,525 | 18,578 | $642,910 | $628,264 | 97.7% |
| 0004A | Fee covid-19 vac 1 res | Office | 2021 | 12,122 | 12,123 | $484,920 | $484,920 | 100.0% |
| 0001A | Adm sarscov2 30mcg/0.3ml 1st | Office | 2021 | 17,255 | 17,264 | $363,960 | $356,201 | 97.9% |
About Dr. Robert Jacobson, M.D
Dr. Robert Jacobson, M.D is a Pediatrics healthcare provider based in Rochester, Minnesota. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/15/2006. The National Provider Identifier (NPI) number assigned to this provider is 1790759728.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Jacobson, M.D has received a total of $48,036 in payments from pharmaceutical and medical device companies, with $1,854 received in 2024. These payments were reported across 65 transactions from 1 company. The most common payment nature is "Consulting Fee" ($48,036).
As a Medicare-enrolled provider, Jacobson has provided services to 119,847 Medicare beneficiaries, totaling 120,059 services with total Medicare billing of $4.7M. Data is available for 4 years (2020–2023), covering 40 distinct procedure/service records.
Ad
Practice Information
- Specialty Pediatrics
- Location Rochester, MN
- Active Since 02/15/2006
- Last Updated 08/14/2020
- Taxonomy Code 208000000X
- Entity Type Individual
- NPI Number 1790759728
Products in Payments
- V114 (Biological) $19,250
- GARDASIL (Biological) $13,738
- GARDASIL9 (Biological) $4,600
- GARDASIL 9 (Biological) $1,275
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pediatrics Doctors in Rochester
Rachael Phelps, M.d, M.D
Pediatrics — Payments: $169,813
Pediatrics $169,813
Partha Ghosh, Md, MD
Pediatrics — Payments: $99,006
Pediatrics $99,006
Jason Anderson, Md, MD
Pediatrics — Payments: $61,051
Pediatrics $61,051
Fatima Ali-Ahmed, M.d, M.D
Pediatrics — Payments: $27,406
Pediatrics $27,406
Samar Ibrahim, Mb, Chb, MB, CHB
Pediatrics — Payments: $26,378
Pediatrics $26,378
Keith Coffman, Md, MD
Pediatrics — Payments: $24,689
Pediatrics $24,689